Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments-Reference-Cited by-同舟云学术

Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments

Published:2020-07 Issue:3 Volume:107 Page:579-586
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Klement Rainer J.,Sonke Jan-Jakob,Allgäuer Michael,Andratschke Nicolaus,Appold Steffen,Belderbos José,Belka Claus,Blanck Oliver,Dieckmann Karin,Eich Hans T.,Mantel Frederick,Eble Michael,Hope Andrew,Grosu Anca L.,Nevinny-Stickel Meinhard,Semrau Sabine,Sweeney Reinhart A.,Hörner-Rieber Juliane,Werner-Wasik Maria,Engenhart-Cabillic Rita,Ye Hong,Grills Inga,Guckenberger Matthias

Funder

Elekta Lung Research Group

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference43 articles.

1. Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer;Guckenberger;Strahlenther Onkol,2014

2. SABR in high-risk prostate cancer: Outcomes from 2 prospective clinical trials with and without elective nodal irradiation;Alayed;Int J Radiat Oncol Biol Phys,2019

3. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma;Brunner;Radiother Oncol,2019

4. Stereotactic body radiotherapy for oligometastases;Tree;Lancet Oncol,2013

5. Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases;Lewis;Am J Clin Oncol,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New diagnostic and nonsurgical local treatment modalities for early stage lung cancer;Lung Cancer;2024-10

2. Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials;European Journal of Cancer;2024-09

3. Refining Treatment Planning in STereotactic Arrhythmia Radioablation: Benchmark Results and Consensus Statement From the STOPSTORM.eu Consortium;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery;Strahlentherapie und Onkologie;2024-07-12

5. Treatment planning and delivery practice of lung SBRT: Results of the 2022 ESTRO physics survey;Radiotherapy and Oncology;2024-07